Immune responses to AAV vectors, from bench to bedside
The recent wave of clinical studies demonstrating long-term therapeutic efficacy highlights the enormous potential of gene therapy as an approach to the treatment of inherited disorders and cancer. While in recent years lentiviral vectors have dominated the field of ex vivo gene therapy in man, aden...
Saved in:
Main Author: | Hildegard Buning (auth) |
---|---|
Other Authors: | Federico Mingozzi (auth), Etiena Basner Tschakarjan (auth), Anne Galy (auth) |
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Frontiers Media SA
2015
|
Series: | Frontiers Research Topics
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine
by: Thomas F. Baumert
Published: (2019) -
Orchestration of an Immune Response to Respiratory Pathogens
Published: (2019) -
Interaction of Nanomaterials with the Immune System: Role in Nanosafety and Nanomedicinenanomedicine
by: Paulo Bonan
Published: (2018) -
Epitope Discovery and Synthetic Vaccine Design
by: Clarisa Beatriz Palatnik-de-Sousa
Published: (2018) -
Protective Immune Response to Dengue Virus Infection and Vaccines: perspectives from the field to the bench
by: Scott Halstead
Published: (2015)